Hxy no longer under patent protection as it is generic, and thus the majority of the manufacturing is done by generic drug companies.

You most likely are confusing molecules with Ivermectin, which Merck did market for HUMANS, however that is also generic and most manufacturing done by generic drug companies as well.

Cole, you're probably smart enough to realize that the purpose for the demonization of cheap generic therapies that work is to pave way for PATENTED new therapies with very flimsy clinical data.

Incredible how Merck rejected the idea of using Ivermectin, as it again has no patent protection, and they magically developed a NEW antiviral with patent protection, A very questionable and weak study, and a poor safety profile.

-------------------------
Brevard Surf Report